<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="clcn7" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">clcn7</book-part-id>
      <title-group>
        <title><italic toggle="yes">CLCN7</italic>-Related Osteopetrosis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sobacchi</surname>
            <given-names>Cristina</given-names>
          </name>
          <degrees>MS</degrees>
          <aff>CNR-IRGB, Milan Unit<break/>Humanitas Clinical and Research Center<break/>Rozzano, Italy</aff>
          <email>cristina.sobacchi@humanitasresearch.it</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Villa</surname>
            <given-names>Anna</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>CNR-IRGB, Milan Unit<break/>Humanitas Clinical and Research Center<break/>Rozzano, Italy</aff>
          <email>anna.villa@humanitasresearch.it</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Schulz</surname>
            <given-names>Ansgar</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Universit&#x000e4;tsklinik f&#x000fc;r Kinder- und Jugendmedizin<break/>Ulm, Germany</aff>
          <email>ansgar.schulz@uniklinik-ulm.de</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kornak</surname>
            <given-names>Uwe</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Institut f&#x000fc;r Medizinische Genetik und Humangenetik<break/>Charit&#x000e9; Universit&#x000e4;tsmedizin<break/>Berlin, Germany</aff>
          <email>uwe.kornak@charite.de</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>12</day>
          <month>2</month>
          <year>2007</year>
        </date>
        <date date-type="updated">
          <day>9</day>
          <month>6</month>
          <year>2016</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="cc2-leuk" document-type="chapter"><italic toggle="yes">CLCN2</italic>-Related Leukoencephalopathy</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="clpb-def" document-type="chapter">CLPB Deficiency</related-object>
      <abstract id="clcn7.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>The spectrum of <italic toggle="yes">CLCN7</italic>-related osteopetrosis includes infantile malignant <italic toggle="yes">CLCN7</italic>-related recessive osteopetrosis (ARO), intermediate autosomal osteopetrosis (IAO), and autosomal dominant osteopetrosis type II (ADOII, Albers-Sch&#x000f6;nberg disease).</p>
          <list list-type="bullet">
            <list-item>
              <p>Onset of ARO is in infancy. Findings may include: fractures; poor growth; sclerosis of the skull base (with or without choanal stenosis or hydrocephalus) resulting in optic nerve compression, facial palsy, and hearing loss; absence of the bone marrow cavity resulting in severe anemia and thrombocytopenia; dental abnormalities, odontomas, and risk for mandibular osteomyelitis; and hypocalcemia with tetanic seizures and secondary hyperparathyroidism. Without treatment maximal life span in ARO is ten years.</p>
            </list-item>
            <list-item>
              <p>Onset of IAO is in childhood. Findings may include fractures after minor trauma, characteristic skeletal radiographic changes found incidentally, mild anemia, and occasional visual impairment secondary to optic nerve compression. Life expectancy in IAO is usually normal.</p>
            </list-item>
            <list-item>
              <p>Onset of ADOII is usually late childhood or adolescence. Findings may include: fractures (in any long bone and/or the posterior arch of a vertebra), scoliosis, hip osteoarthritis, and osteomyelitis of the mandible or septic osteitis or osteoarthritis elsewhere. Cranial nerve compression is rare.</p>
            </list-item>
          </list>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p><italic toggle="yes">CLCN7</italic>-related osteopetrosis is suspected with identification of radiographic changes that are pathognomonic in ARO (generalized osteosclerosis, club-shaped long bones, osteosclerosis of the skull base, bone-within-bone appearance) and characteristic in ADOII (osteosclerosis of the spine ["sandwich vertebra" appearance], bone-within-bone appearance (mainly iliac wings), Erlenmeyer-shaped femoral metaphysis, mild osteosclerosis of the skull base, transverse bands of osteosclerosis in long bones). Identification of pathogenic variants in <italic toggle="yes">CLCN7</italic> establishes the diagnosis.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p>
            <italic toggle="yes">Treatment of manifestations:</italic>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>ARO. Calcium supplementation for hypocalcemic convulsions; management of calcium homeostasis per individual needs; erythrocyte or platelet transfusions as needed; antibiotics for leukocytopenia; immunoglobulins for hypogammaglobulinemia; surgical decompression of the optic nerve; treatment of fractures by an experienced orthopedist; dental care with attention to tooth eruption, ankylosis, abscesses, cysts, and fistulas.</p>
            </list-item>
            <list-item>
              <p>ADOII. Orthopedic treatment for fractures and arthritis with attention to potential post-surgical complications (delayed union or non-union of fractures, infection); fractures near joints may require total joint arthroplasty.</p>
            </list-item>
          </list>
          <p><italic toggle="yes">Prevention of primary manifestations:</italic> ARO. Hematopoietic stem cell transplantation (HSCT) can be curative; however, cranial nerve dysfunction is usually irreversible, and progressive neurologic sequelae occur in children with the neuronopathic form even after successful HSCT.</p>
          <p>
            <italic toggle="yes">Prevention of secondary complications:</italic>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>ARO. Restricted intake of calcium and vitamin D just before, during, and following HSCT to prevent hypercalcemia.</p>
            </list-item>
            <list-item>
              <p>ADOII. Good routine dental care and oral hygiene to help prevent osteomyelitis of the mandible.</p>
            </list-item>
          </list>
          <p><italic toggle="yes">Surveillance:</italic> ARO. Complete blood count and ophthalmologic examination at least once a year; follow up per the transplantation center following HSCT.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> ADOII. Activities with high fracture risk.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>ARO is inherited in an autosomal recessive manner; ADOII is inherited in an autosomal dominant manner; about 40% of IAO is inherited in an autosomal recessive manner and about 60% in an autosomal dominant manner.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Autosomal recessive inheritance.</bold> At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. In general, individuals with ARO only reproduce if successfully treated by HSCT.</p>
            </list-item>
            <list-item>
              <p><bold>Autosomal dominant inheritance.</bold> Most individuals diagnosed with autosomal dominant <italic toggle="yes">CLCN7</italic>-related osteopetrosis have an affected parent. The proportion of cases caused by <italic toggle="yes">de novo</italic> pathogenic variants is unknown. Each child of an individual with autosomal dominant <italic toggle="yes">CLCN7</italic>-related osteopetrosis has a 50% chance of inheriting the pathogenic variant.</p>
            </list-item>
          </list>
          <p>Prenatal diagnosis for pregnancies at increased risk for ADOII and ARO is possible if the pathogenic variant(s) have been identified in the family.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="clcn7.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="clcn7.Tc" orientation="portrait" position="anchor">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_clcn7.Tc_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">CLCN7</italic>-Related Osteopetrosis: Included Phenotypes</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_clcn7.Tc_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Infantile malignant <italic toggle="yes">CLCN7</italic>-related autosomal recessive osteopetrosis (ARO)</p></list-item><list-item><p>Intermediate autosomal osteopetrosis (IAO)</p></list-item><list-item><p>Autosomal dominant osteopetrosis type II (ADOII)</p></list-item></list>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="clcn7.Diagnosis">
        <title>Diagnosis</title>
        <p>The spectrum of <italic toggle="yes">CLCN7</italic>-related osteopetrosis includes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Infantile malignant <italic toggle="yes">CLCN7</italic>-related autosomal recessive osteopetrosis (ARO);</p>
          </list-item>
          <list-item>
            <p>Intermediate autosomal osteopetrosis (IAO);</p>
          </list-item>
          <list-item>
            <p>Autosomal dominant osteopetrosis type II (ADOII, Albers-Sch&#x000f6;nberg disease).</p>
          </list-item>
        </list>
        <sec id="clcn7.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>A <italic toggle="yes">CLCN7</italic>-related osteopetrosis <bold>should be suspected</bold> in individuals with osteosclerosis noted on radiographs, which may be accompanied by hypocalcemia and resulting convulsions, anemia, thrombocytopenia, visual impairment, and/or CNS involvement (see <xref ref-type="table" rid="clcn7.T.diagnostic_features_of_the_subty">Table 1</xref>).</p>
          <table-wrap id="clcn7.T.diagnostic_features_of_the_subty" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Diagnostic Features of the Subtypes of <italic toggle="yes">CLCN7</italic>-Related Osteopetrosis</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_1">Finding</th>
                  <th id="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_2" valign="middle" colspan="3" align="left" scope="colgroup" rowspan="1">Subtype of <italic toggle="yes">CLCN7</italic>-Related Osteopetrosis</th>
                </tr>
                <tr>
                  <th headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_2" id="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">ARO&#x000a0;<sup>1</sup></th>
                  <th headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_2" id="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">IAO&#x000a0;<sup>2</sup></th>
                  <th headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_2" id="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_2_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">ADOII&#x000a0;<sup>3</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Radiographic changes</td>
                  <td headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_2 hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Pathognomonic&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_2 hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Characteristic&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_2 hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">Characteristic&#x000a0;<sup>6</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Hypocalcemia</td>
                  <td headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_2 hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Severe to absent</td>
                  <td headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_2 hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Absent</td>
                  <td headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_2 hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">Absent</td>
                </tr>
                <tr>
                  <td headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Anemia</td>
                  <td headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_2 hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Severe to moderate</td>
                  <td headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_2 hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Mild to absent</td>
                  <td headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_2 hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">Absent</td>
                </tr>
                <tr>
                  <td headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Thrombocytopenia</td>
                  <td headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_2 hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Severe to absent</td>
                  <td headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_2 hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Absent</td>
                  <td headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_2 hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">Absent</td>
                </tr>
                <tr>
                  <td headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Visual impairment</td>
                  <td headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_2 hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Frequent</td>
                  <td headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_2 hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Rare</td>
                  <td headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_2 hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">Very rare</td>
                </tr>
                <tr>
                  <td headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">CNS involvement</td>
                  <td headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_2 hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Severe to absent</td>
                  <td headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_2 hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Absent</td>
                  <td headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_2 hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">Absent</td>
                </tr>
                <tr>
                  <td headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Age of onset of symptoms</td>
                  <td headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_2 hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Birth</td>
                  <td headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_2 hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">First 2 years</td>
                  <td headers="hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_1_2 hd_h_clcn7.T.diagnostic_features_of_the_subty_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">First 10 years</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="clcn7.TF.1.1">
                <label>1. </label>
                <p>ARO = infantile malignant autosomal <italic toggle="yes">CLCN7</italic>-related autosomal recessive osteopetrosis</p>
              </fn>
              <fn id="clcn7.TF.1.2">
                <label>2. </label>
                <p>IAO = intermediate autosomal osteopetrosis</p>
              </fn>
              <fn id="clcn7.TF.1.3">
                <label>3. </label>
                <p>ADOII = autosomal dominant osteopetrosis type II</p>
              </fn>
              <fn id="clcn7.TF.1.4">
                <label>4. </label>
                <p>Generalized osteosclerosis, club-shaped long bones, sclerosis of the skull base, bone-within-bone appearance</p>
              </fn>
              <fn id="clcn7.TF.1.5">
                <label>5. </label>
                <p>Findings similar to ARO, already present in early childhood, but less severe</p>
              </fn>
              <fn id="clcn7.TF.1.6">
                <label>6. </label>
                <p>Findings include:  &#x02022;&#x000a0;Osteosclerosis of the spine ("sandwich vertebrae")  &#x02022;&#x000a0;Bone within bone appearance, mainly in iliac wings  &#x02022;&#x000a0;Erlenmeyer-shaped femoral metaphysis  &#x02022;&#x000a0;Mild osteosclerosis of the skull base  &#x02022;&#x000a0;Transverse bands of osteosclerosis in long bones</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="clcn7.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of a <italic toggle="yes">CLCN7</italic>-related osteopetrosis <bold>is established</bold> in a proband through the identification of biallelic pathogenic variants or a heterozygous pathogenic variant in <italic toggle="yes">CLCN7</italic> by molecular genetic testing (see <xref ref-type="table" rid="clcn7.T.molecular_genetic_testing_used_i">Table 3</xref>).</p>
          <p>Molecular testing approaches can include <bold>single-gene testing</bold> and use of a <bold>multi-gene panel</bold>.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> Sequence analysis of <italic toggle="yes">CLCN7</italic> is performed first followed by gene-targeted deletion/duplication analysis if only one or no pathogenic variant is found.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">CLCN7</italic> and other genes of interest (see <xref ref-type="sec" rid="clcn7.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
            </list-item>
          </list>
          <p>The proportion of all osteopetrosis caused by pathogenic variants in <italic toggle="yes">CLCN7</italic> is summarized in <xref ref-type="table" rid="clcn7.T.proportion_of_osteopetrosis_phen">Table 2</xref>.</p>
          <table-wrap id="clcn7.T.proportion_of_osteopetrosis_phen" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Proportion of Osteopetrosis Phenotype Caused by Pathogenic Variants in <italic toggle="yes">CLCN7</italic></p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_clcn7.T.proportion_of_osteopetrosis_phen_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Osteopetrosis Phenotype</th>
                  <th id="hd_h_clcn7.T.proportion_of_osteopetrosis_phen_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1"># of <italic toggle="yes">CLCN7</italic> Pathogenic Variants</th>
                  <th id="hd_h_clcn7.T.proportion_of_osteopetrosis_phen_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">% of Osteopetrosis Caused by Pathogenic Variants in <italic toggle="yes">CLCN7</italic></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_clcn7.T.proportion_of_osteopetrosis_phen_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Infantile malignant <italic toggle="yes">CLCN7</italic>-related autosomal recessive osteopetrosis (ARO)</td>
                  <td headers="hd_h_clcn7.T.proportion_of_osteopetrosis_phen_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">2</td>
                  <td headers="hd_h_clcn7.T.proportion_of_osteopetrosis_phen_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">13%</td>
                </tr>
                <tr>
                  <td headers="hd_h_clcn7.T.proportion_of_osteopetrosis_phen_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">Intermediate autosomal osteopetrosis (IAO)</td>
                  <td headers="hd_h_clcn7.T.proportion_of_osteopetrosis_phen_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">2</td>
                  <td headers="hd_h_clcn7.T.proportion_of_osteopetrosis_phen_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">40%&#x000a0;<sup>1</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_clcn7.T.proportion_of_osteopetrosis_phen_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">1</td>
                  <td headers="hd_h_clcn7.T.proportion_of_osteopetrosis_phen_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">60%&#x000a0;<sup>1</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_clcn7.T.proportion_of_osteopetrosis_phen_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Autosomal dominant osteopetrosis type II (ADOII)</td>
                  <td headers="hd_h_clcn7.T.proportion_of_osteopetrosis_phen_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">1</td>
                  <td headers="hd_h_clcn7.T.proportion_of_osteopetrosis_phen_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">75%&#x000a0;<sup>2</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="clcn7.TF.2.1">
                <label>1. </label>
                <p><xref ref-type="bibr" rid="clcn7.REF.camposxavier.2003.186">Campos-Xavier et al [2003]</xref>, <xref ref-type="bibr" rid="clcn7.REF.frattini.2003.1740">Frattini et al [2003]</xref>, <xref ref-type="bibr" rid="clcn7.REF.pangrazio.2010.e1071">Pangrazio et al [2010]</xref></p>
              </fn>
              <fn id="clcn7.TF.2.2">
                <label>2. </label>
                <p><xref ref-type="bibr" rid="clcn7.REF.del_fattore.2006.315">Del Fattore et al [2006]</xref> found <italic toggle="yes">CLCN7</italic> pathogenic variants in 78% of individuals with ADOII; <xref ref-type="bibr" rid="clcn7.REF.frattini.2003.1740">Frattini et al [2003]</xref> found <italic toggle="yes">CLCN7</italic> pathogenic variants in 72% of individuals with ADOII. In other cohorts, rates may be higher [unpublished observations]. It remains possible that pathogenic variants in another gene cause the ADOII phenotype in a subset of cases.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <table-wrap id="clcn7.T.molecular_genetic_testing_used_i" orientation="portrait" position="anchor">
            <label>Table 3. </label>
            <caption>
              <p>Molecular Genetic Testing Used in <italic toggle="yes">CLCN7</italic>-Related Osteopetrosis</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_clcn7.T.molecular_genetic_testing_used_i_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_clcn7.T.molecular_genetic_testing_used_i_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_clcn7.T.molecular_genetic_testing_used_i_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_clcn7.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">CLCN7</italic>
                  </td>
                  <td headers="hd_h_clcn7.T.molecular_genetic_testing_used_i_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_clcn7.T.molecular_genetic_testing_used_i_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~95%&#x000a0;<sup>4</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_clcn7.T.molecular_genetic_testing_used_i_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_clcn7.T.molecular_genetic_testing_used_i_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>6,&#x000a0;7</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="clcn7.TF.3.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="clcn7" object-id="clcn7.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="clcn7.TF.3.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="clcn7.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="clcn7.TF.3.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice-site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="clcn7.TF.3.4">
                <label>4. </label>
                <p>Virtually all pathogenic variants reported in the literature have been identified by sequencing of the gene, the majority by classical Sanger sequencing, more recently also by exome or gene panel-based sequencing [Author observation].</p>
              </fn>
              <fn id="clcn7.TF.3.5">
                <label>5. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used can include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="clcn7.TF.3.6">
                <label>6. </label>
                <p>Example of homozygous 101-kb contiguous gene deletion including exons 7-25 of <italic toggle="yes">CLCN7</italic> [<xref ref-type="bibr" rid="clcn7.REF.pangrazio.2012.250">Pangrazio et al 2012</xref>]</p>
              </fn>
              <fn id="clcn7.TF.3.7">
                <label>7. </label>
                <p>No data on detection rate of gene-targeted deletion/duplication analysis are available.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="clcn7.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="clcn7.Clinical_Description">
          <title>Clinical Description</title>
          <sec id="clcn7.Infantile_Malignant_CLCN7Related_A">
            <title>Infantile Malignant <italic toggle="yes">CLCN7</italic>-Related Autosomal Recessive Osteopetrosis (ARO)</title>
            <p>ARO is a systemic, life-threatening disorder. Without treatment, life span is approximately ten years (although rare exceptions of far longer survival have occurred). Possible clinical manifestations of ARO:</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Fractures.</bold> The near-complete absence of osteoclastic bone resorption caused by the loss of H(+)/Cl(-) exchange transporter 7 (also known as ClC-7) leads to osteosclerosis of the whole skeleton within the first few months after birth (<xref ref-type="fig" rid="clcn7.F1">Figure 1</xref>). Because of defective microarchitecture, the bones become brittle, resulting in recurrent fractures (usually of the long bones).</p>
              </list-item>
              <list-item>
                <p><bold>Reduced growth.</bold> Resorption of cartilage and bone at the growth plate is a prerequisite for longitudinal growth; its absence results in variable growth retardation. In severely affected children, body length at age 12 months is as much as 5 cm below the third centile.</p>
              </list-item>
              <list-item>
                <p><bold>Skull.</bold> In some severely affected children, macrocephaly and frontal bossing develop within the first year. This is not necessarily paralleled by sclerosis of the cranial vault. The sclerosis of the skull base often leads to choanal stenosis. Skull changes may also cause hydrocephalus.</p>
              </list-item>
              <list-item>
                <p>Neurologic complications</p>
                <list list-type="bullet">
                  <list-item>
                    <p>Visual impairment beginning shortly after birth is common. In most cases it is caused by optic nerve compression within the osteosclerotic skull base.</p>
                  </list-item>
                  <list-item>
                    <p>A prominent and large anterior fontanel is common and sometimes associated with hydrocephalus, possibly caused by obstruction of cerebral blood flow and cerebrospinal fluid (CSF) circulation as a result of hyperostosis.</p>
                  </list-item>
                  <list-item>
                    <p>Facial palsy caused by facial nerve entrapment is an uncommon manifestation.</p>
                  </list-item>
                  <list-item>
                    <p>Seizures can result from hypocalcemia.</p>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p><bold>Neuronopathic form.</bold> If seizures appear together with normal serum calcium concentration and developmental delay, a neuronopathic form must be considered. In these cases the neuronal phenotype resembles <related-object link-type="booklink" source-id="gene" document-id="ncl" document-type="chapter">neuronal ceroid-lipofuscinosis</related-object> [<xref ref-type="bibr" rid="clcn7.REF.steward.2003.87">Steward 2003</xref>]. In this subset of very severely affected children, primary degeneration of the retina and CNS occurs. It is important to differentiate these rare primary neurologic manifestations of the neuronopathic form of ARO (which has a poor prognosis) from more common secondary lesions resulting from hyperostosis of the skull base. It is noteworthy that pathologic EEG changes with a characteristic pattern of very frequent multifocal spikes and sharp waves usually precede the clinical symptoms and brain MRI findings of neurodegeneration [A Schulz, unpublished results].</p>
                <p>The basis of the neuronopathic form of ARO is as yet incompletely understood, but neurologic complications are more common and more severe in persons with <italic toggle="yes">CLCN7</italic> pathogenic variants than in those with <italic toggle="yes">TCIRG1</italic>-related ARO [<xref ref-type="bibr" rid="clcn7.REF.pangrazio.2010.e1071">Pangrazio et al 2010</xref>; A Schulz, unpublished results], while all individuals with <italic toggle="yes">OSTM1</italic>-related ARO have CNS involvement. This is mirrored by neurodegeneration in <italic toggle="yes">Clcn7</italic>- and <italic toggle="yes">Ostm1</italic>-null mice [<xref ref-type="bibr" rid="clcn7.REF.kasper.2005.1079">Kasper et al 2005</xref>, <xref ref-type="bibr" rid="clcn7.REF.lange.2006.220">Lange et al 2006</xref>]. Ostm1 is a beta subunit of ClC-7 and is required for its transport activity [<xref ref-type="bibr" rid="clcn7.REF.leisle.2011.2140">Leisle et al 2011</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>Otologic manifestations.</bold> According to <xref ref-type="bibr" rid="clcn7.REF.dozier.2005.762">Dozier et al [2005]</xref>, 78% of individuals with ARO showed variable hearing loss. Poor pneumatization of the mastoid bone and narrowing of the external auditory canal, eustachian tube, and internal auditory canal frequently lead to otitis media, conductive and sensorineural hearing loss, and facial nerve paralysis [<xref ref-type="bibr" rid="clcn7.REF.dozier.2005.762">Dozier et al 2005</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>Dental.</bold> Oral problems in ARO are delayed tooth eruption, hypodontia, malformed teeth, enamel hypoplasia, hypomineralization of enamel and dentin, the presence of odontomas, and severe mandibular osteomyelitis. Even if the primary dentition is impaired, the secondary dentition can be normal after successful stem cell transplantation [<xref ref-type="bibr" rid="clcn7.REF.j_levik.2002.537">J&#x000e4;levik et al 2002</xref>, <xref ref-type="bibr" rid="clcn7.REF.helfrich.2005.115">Helfrich 2005</xref>, <xref ref-type="bibr" rid="clcn7.REF.luzzi.2006.39">Luzzi et al 2006</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>Hypocalcemia.</bold> Hypocalcemia may result in tetanic seizures and secondary hyperparathyroidism.</p>
              </list-item>
              <list-item>
                <p><bold>Anemia and thrombocytopenia.</bold> The absence of the bone marrow cavity leads to extramedullary hematopoiesis, hepatosplenomegaly, anemia, and thrombocytopenia. The bleeding associated with thrombocytopenia can be severe and life threatening, especially in the CNS.</p>
              </list-item>
              <list-item>
                <p><bold>Immune function.</bold> Immune function may be impaired. Leukocytosis, present in the early stage of the disease, can become leukocytopenia. In conjunction with the frequently observed choanal stenosis, impaired immune function may lead to chronic rhinitis. Defective superoxide generation by granulocytes and monocytes has been reported in ARO [<xref ref-type="bibr" rid="clcn7.REF.wilson.2000.449">Wilson &#x00026; Vellodi 2000</xref>].</p>
              </list-item>
            </list>
          </sec>
          <sec id="clcn7.Intermediate_Autosomal_Osteopetros">
            <title>Intermediate Autosomal Osteopetrosis (IAO)</title>
            <p>IAO is characterized by childhood onset with a milder course than ARO. Life expectancy is normal in most cases. Children may present with fractures after minor trauma or characteristic changes on x-rays obtained for other clinical indications. Hematologic signs are milder than those in ARO and are usually restricted to anemia. Although CNS involvement is usually absent, visual impairment secondary to optic nerve encroachment can occur [<xref ref-type="bibr" rid="clcn7.REF.camposxavier.2003.186">Campos-Xavier et al 2003</xref>, <xref ref-type="bibr" rid="clcn7.REF.frattini.2003.1740">Frattini et al 2003</xref>]. Recently, recessive hypomorphic intronic pathogenic variants in <italic toggle="yes">TCIRG1</italic> have been reported in an intermediate form of the disease [<xref ref-type="bibr" rid="clcn7.REF.sobacchi.2014.1646">Sobacchi et al 2014</xref>, <xref ref-type="bibr" rid="clcn7.REF.palagano.2015.1814">Palagano et al 2015</xref>]. These variants caused aberrant splicing, but also allowed the production of a limited amount of normal transcript sufficient to dampen the severity of the disease usually associated with pathogenic variants in <italic toggle="yes">TCIRG1</italic>. In fact, three individuals with such variants at the homozygous state reached adulthood in relatively good health, the major issues being recurrent non-traumatic fractures [<xref ref-type="bibr" rid="clcn7.REF.palagano.2015.1814">Palagano et al 2015</xref>].</p>
          </sec>
          <sec id="clcn7.Autosomal_Dominant_Osteopetrosis_T">
            <title>Autosomal Dominant Osteopetrosis Type II (ADOII)</title>
            <p>Although ADOII is sometimes called "benign osteopetrosis," as many as 60%-80% of individuals with radiologic signs of ADOII experience clinical problems (see <xref ref-type="fig" rid="clcn7.F2">Figure 2</xref>).</p>
            <p>Onset of clinical and radiologic manifestations of ADOII is usually in late childhood or adolescence, although earlier occurrence has been reported. Osteosclerosis of the spine predominates, with a "sandwich vertebra" appearance, a diagnostic criterion for ADOII. Most affected individuals have a "bone-within-bone" appearance primarily in the iliac wings, but also in other bones. Transverse bands of sclerosis, perpendicular to the main axis, are often observed in long bones. Increase in the skull base density can be seen [<xref ref-type="bibr" rid="clcn7.REF.b_nichou.2000.87">B&#x000e9;nichou et al 2000</xref>, <xref ref-type="bibr" rid="clcn7.REF.cleiren.2001.2861">Cleiren et al 2001</xref>].</p>
            <p>Clinical findings vary even within the same family [<xref ref-type="bibr" rid="clcn7.REF.chu.2006.1089">Chu et al 2006</xref>]. In three families in which most affected individuals had mild ADOII, early-onset disease, anemia, and blindness caused by optic nerve compression were observed in some affected family members; this phenotype has been called &#x0201c;intermediate osteopetrosis&#x0201d; because of its overlap with mild ARO.</p>
            <p>The main complications affect the skeleton:</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Fractures</bold> occur in about 80% of affected individuals in the largest study, with a mean of three fractures per person [<xref ref-type="bibr" rid="clcn7.REF.b_nichou.2000.87">B&#x000e9;nichou et al 2000</xref>]. Some individuals had more than ten fractures. The most frequently affected bone is the femur, but fractures occur in any long bone and in the posterior arch of the vertebrae, thereby inducing spondylolisthesis.</p>
              </list-item>
              <list-item>
                <p><bold>Scoliosis</bold> is seen in a number of cases.</p>
              </list-item>
              <list-item>
                <p><bold>Hip osteoarthritis</bold> is common (27%) and could be caused by the excessive toughness of the subchondral bone.</p>
              </list-item>
              <list-item>
                <p><bold>Osteomyelitis</bold> of the mandible is often associated with dental abscess or caries [<xref ref-type="bibr" rid="clcn7.REF.b_nichou.2000.87">B&#x000e9;nichou et al 2000</xref>]. Septic osteitis or osteoarthritis at other localizations can also occur.</p>
              </list-item>
            </list>
            <p>Cranial nerve compression caused by osteosclerosis of the skull base is rare. Hearing loss and visual loss occurs in fewer than 5% of affected individuals.</p>
          </sec>
        </sec>
        <sec id="clcn7.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Except for the following, no clear genotype-phenotype correlation exists:</p>
          <list list-type="bullet">
            <list-item>
              <p>Pathogenic nonsense variants and indel and splicing defects in <italic toggle="yes">CLCN7</italic> are more likely to cause ARO [Author, personal observation].</p>
            </list-item>
            <list-item>
              <p>The proportion of pathogenic variants in the C-terminal cystathionine &#x003b2;-synthase (CBS) domains of the H(+)/Cl(-) exchange transporter 7 is higher in ADOII than in ARO [Author, personal observation].</p>
            </list-item>
          </list>
        </sec>
        <sec id="clcn7.Penetrance">
          <title>Penetrance</title>
          <p>Depending on the population and the pathogenic variants studied, penetrance ranges from 60% to 90% in families with ADOII [<xref ref-type="bibr" rid="clcn7.REF.bollerslev.1989.45">Bollerslev 1989</xref>, <xref ref-type="bibr" rid="clcn7.REF.b_nichou.2000.87">B&#x000e9;nichou et al 2000</xref>, <xref ref-type="bibr" rid="clcn7.REF.waguespack.2003.1513">Waguespack et al 2003</xref>].</p>
        </sec>
        <sec id="clcn7.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of ADOII has been estimated at up to 1:20,000 [<xref ref-type="bibr" rid="clcn7.REF.b_nichou.2001.647">B&#x000e9;nichou et al 2001</xref>]. The disease is probably underdiagnosed in milder cases.</p>
          <p>ARO is less common, with a prevalence around 1:250,000. Higher frequencies are reported in specific geographic areas, most likely as a result of a founder effect: one in 3500 newborns in Chuvashiya and one in 14,000 newborns in the Mari population in Russia [<xref ref-type="bibr" rid="clcn7.REF.bliznetz.2009.664">Bliznetz et al 2009</xref>]; about 5.4:100,000 births in the Middle East [<xref ref-type="bibr" rid="clcn7.REF.souraty.2007.188">Souraty et al 2007</xref>]. Higher frequencies are also registered in Costa Rica [<xref ref-type="bibr" rid="clcn7.REF.sobacchi.2001.1767">Sobacchi et al 2001</xref>] and in the Swedish province of V&#x000e4;sterbotten [<xref ref-type="bibr" rid="clcn7.REF.pangrazio.2013.1041">Pangrazio et al 2013</xref>].</p>
        </sec>
      </sec>
      <sec id="clcn7.Genetically_Related_Allelic_Disord">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with pathogenic variants in <italic toggle="yes">CLCN7</italic>.</p>
      </sec>
      <sec id="clcn7.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>
          <bold>Autosomal recessive osteopetrosis</bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p><bold>ARO secondary to <italic toggle="yes">TCIRG1</italic> pathogenic variants</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/259700">259700</ext-link>). More than 50% of ARO is caused by pathogenic variants in <italic toggle="yes">TCIRG1</italic>. ARO caused by <italic toggle="yes">TCIRG1</italic> pathogenic variants can be distinguished from <italic toggle="yes">CLCN7</italic>-related disease [<xref ref-type="bibr" rid="clcn7.REF.frattini.2000.343">Frattini et al 2000</xref>, <xref ref-type="bibr" rid="clcn7.REF.kornak.2000.2059">Kornak et al 2000</xref>] based on the higher frequency of neurodevelopmental delay and seizures in the latter form of osteopetrosis.</p>
          </list-item>
          <list-item>
            <p><bold>Osteoclast-poor ARO.</bold> Osteoclast-poor ARO is characterized by onset within the first year of life and typical ARO manifestations. Investigation of a bone biopsy is prerequisite for a reliable diagnosis. However, <italic toggle="yes">TNFSF11</italic> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/259710">259710</ext-link>) pathogenic variants cause a slight T-cell defect and <italic toggle="yes">TNFRSF11A</italic> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/612301">612301</ext-link>) pathogenic variants can lead to hypogammaglobulinemia similar to a common variable immune deficiency (CVID) [<xref ref-type="bibr" rid="clcn7.REF.sobacchi.2007.960">Sobacchi et al 2007</xref>, <xref ref-type="bibr" rid="clcn7.REF.guerrini.2008.64">Guerrini et al 2008</xref>]. Ruling out a <italic toggle="yes">TNFSF11</italic> -related ARO is crucial since HSC transplantation is not successful in these affected individuals.</p>
          </list-item>
          <list-item>
            <p><bold>ARO with renal tubular acidosis (RTA)</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/259730">259730</ext-link>). The onset of ARO with RTA is usually later than in the malignant infantile form of ARO and the disease course is milder. In addition to the generalized osteosclerosis, cerebral calcifications are typical and may be associated with intellectual disability [<xref ref-type="bibr" rid="clcn7.REF.jacquemin.1998.662">Jacquemin et al 1998</xref>]. Pathogenic variants are found in <italic toggle="yes">CA2</italic>, the gene encoding carbonic anhydrase 2 [<xref ref-type="bibr" rid="clcn7.REF.bolt.2005.e71">Bolt et al 2005</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>ARO secondary to <italic toggle="yes">OSTM1</italic> pathogenic variants</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/259720">259720</ext-link>). Approximately 4% of ARO is caused by pathogenic variants in <italic toggle="yes">OSTM1</italic>. <italic toggle="yes">OSTM1</italic> pathogenic variants cause an extremely severe form of ARO with CNS involvement [<xref ref-type="bibr" rid="clcn7.REF.pangrazio.2006.1098">Pangrazio et al 2006</xref>]. Deletions in the OSTM1 locus have also been observed [<xref ref-type="bibr" rid="clcn7.REF.ott.2013.292">Ott et al 2013</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>ARO secondary to <italic toggle="yes">PLEKHM1</italic> pathogenic variants</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/611497">611497</ext-link>). Two individuals with <italic toggle="yes">PLEKHM1</italic> pathogenic variants have been described to date. The phenotype appears to be very mild and can regress with increasing age [<xref ref-type="bibr" rid="clcn7.REF.van_wesenbeeck.2007.919">Van Wesenbeeck et al 2007</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>ARO secondary to <italic toggle="yes">SNX10</italic> pathogenic variants</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/615085">615085</ext-link>). Approximately 4% of ARO is caused by pathogenic variants in <italic toggle="yes">SNX10</italic>; in particular<italic toggle="yes">,</italic> &#x0201c;V&#x000e4;sterbottenian osteopetrosis&#x0201d; is caused by pathogenic variants in this gene. This form of ARO appears to be slightly less severe than the <italic toggle="yes">CLCN7</italic>-related form. However, loss of vision, anemia, and bone fragility are frequently observed, warranting the use of HSCT [<xref ref-type="bibr" rid="clcn7.REF.aker.2012.221">Aker et al 2012</xref>, <xref ref-type="bibr" rid="clcn7.REF.pangrazio.2013.1041">Pangrazio et al 2013</xref>].</p>
          </list-item>
        </list>
        <p>See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/phenotypicSeries/PS259700">Osteopetrosis, autosomal recessive: OMIM Phenotypic Series</ext-link> to view genes associated with this phenotype in OMIM</p>
        <p>
          <bold>Mild ARO</bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p><bold>ARO secondary to intronic <italic toggle="yes">TCIRG1</italic> pathogenic variants</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/259700">259700</ext-link>). A mild form of ARO can be caused by deep intronic or splice-site variants in <italic toggle="yes">TCIRG1</italic> [<xref ref-type="bibr" rid="clcn7.REF.sobacchi.2014.1646">Sobacchi et al 2014</xref>, <xref ref-type="bibr" rid="clcn7.REF.palagano.2015.1814">Palagano et al 2015</xref>]. This form can be very similar to <italic toggle="yes">CLCN7</italic>-related IAO or ADOII.</p>
          </list-item>
        </list>
        <p>
          <bold>Autosomal dominant osteopetrosis</bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Autosomal dominant osteopetrosis type I (ADOI)</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/607634">607634</ext-link>). Osteosclerosis in ADOI is most pronounced in the skull vault and does not lead to sandwich vertebrae. It is debated whether this disease entity should be called endosteal hyperostosis or high bone mass disorder, as osteopetrosis should be reserved for osteoclast-related disorders. ADOI is not associated with an increased fracture rate. Pathogenic variants in <italic toggle="yes">LRP5</italic> are causative [<xref ref-type="bibr" rid="clcn7.REF.van_wesenbeeck.2003.763">Van Wesenbeeck et al 2003</xref>].</p>
          </list-item>
        </list>
        <p>See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/phenotypicSeries/PS607634">Osteopetrosis, autosomal dominant: OMIM Phenotypic Series</ext-link> to view genes associated with this phenotype in OMIM.</p>
        <p>
          <bold>Other</bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Pyknodysostosis</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/265800">265800</ext-link>). Affected individuals usually have small stature (adult height &#x0003c;150 cm), frontal bossing, wormian bones, a persistent (open) anterior fontanel, and acroosteolysis of the terminal phalanges [<xref ref-type="bibr" rid="clcn7.REF.vanhoenacker.2000.1423">Vanhoenacker et al 2000</xref>]. The bones are generally sclerotic and prone to fractures. In some patients the clinical presentation can resemble IAO [<xref ref-type="bibr" rid="clcn7.REF.pangrazio.2014.122">Pangrazio et al 2014</xref>]. Pyknodysostosis is caused by pathogenic variants in <italic toggle="yes">CTSK</italic>, the gene encoding cathepsin K [<xref ref-type="bibr" rid="clcn7.REF.gelb.1996.1236">Gelb et al 1996</xref>], and is inherited in an autosomal recessive manner.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="sost" document-type="chapter"><bold><italic toggle="yes">SOST</italic>-related sclerosing bone dysplasias</bold></related-object><bold>,</bold> including van Buchem disease and sclerosteosis, is characterized by moderate to gross skull hyperostosis leading to cranial nerve dysfunction, mandibular enlargement, and generalized osteosclerosis. Sclerosteosis also comprises syndactyly and tall stature and can be lethal as a result of increased intracranial pressure [<xref ref-type="bibr" rid="clcn7.REF.hamersma.2003.192">Hamersma et al 2003</xref>]. The <italic toggle="yes">SOST</italic>-related sclerosing bone dysplasias are inherited in an autosomal recessive manner.</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="cranio-md" document-type="chapter"><bold>Autosomal dominant craniometaphyseal dysplasia</bold></related-object>
<bold>(AD-CMD).</bold> The clinical hallmark of CMD is skull hyperostosis leading to deep-set eyes and paranasal bossing. Facial nerve palsy is common and occurs more frequently than optic nerve compression [<xref ref-type="bibr" rid="clcn7.REF.braun.2001.74">Braun et al 2001</xref>]. The femur shows a modeling defect, but no osteosclerosis. Susceptibility to fractures is not increased. Pathogenic variants in <italic toggle="yes">ANKH</italic> are causative [<xref ref-type="bibr" rid="clcn7.REF.n_rnberg.2001.37">N&#x000fc;rnberg et al 2001</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>Autosomal recessive craniometaphyseal dysplasia (AR-CMD)</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/218400">218400</ext-link>). Affected individuals show typical features of CMD (macrocephaly, hearing loss, skull hyperostosis with paranasal bossing, metaphyseal widening) but less pronounced calvarial thickening [<xref ref-type="bibr" rid="clcn7.REF.iughetti.2000.482">Iughetti et al 2000</xref>]. Due to diaphyseal osteosclerosis the disorder can occasionally resemble mild forms of osteopetrosis. Pathogenic variants in <italic toggle="yes">GJA1</italic> are causative [<xref ref-type="bibr" rid="clcn7.REF.hu.2013.e73576">Hu et al 2013</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>Dysosteosclerosis.</bold> Short stature, sandwich vertebrae, platyspondyly, metaphyseal widening and sclerosis, and often also diaphyseal thickening are characteristic of dysosteosclerosis. <xref ref-type="bibr" rid="clcn7.REF.campeau.2012.4904">Campeau et al [2012]</xref> identified biallelic <italic toggle="yes">SLC29A3</italic> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/612373">612373</ext-link>) variants in two individuals with dysosteosclerosis. The phenotype caused by deep intronic <italic toggle="yes">TCIRG1</italic> pathogenic variants can look similar [U Kornak, unpublished observation].</p>
          </list-item>
          <list-item>
            <p><bold>Leukocyte adhesion deficiency type III (LAD-III)</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/612840">612840</ext-link>). Affected individuals present with recurrent infections and a bleeding diathesis regardless of platelet or leukocyte count. Pathogenic variants in <italic toggle="yes">FERMT3</italic> (encoding fermitin family homolog 3) are causative. In some individuals with LAD-III, a high bone density can be found, since fermitin family homolog 3 (also referred to as kindlin-3) signaling is required for osteoclast-mediated bone resorption [<xref ref-type="bibr" rid="clcn7.REF.crazzolara.2015.1677">Crazzolara et al 2015</xref>].</p>
          </list-item>
        </list>
      </sec>
      <sec id="clcn7.Management">
        <title>Management</title>
        <p>Recently updated guidelines for diagnosis, therapy, and follow up are available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ebmt.org/Contents/Research/TheWorkingParties/IEWP/Documents/00_OP_Guidelines_V3.pdf">online</ext-link>.</p>
        <sec id="clcn7.Evaluations_Following_Initial_Diag">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with infantile malignant <italic toggle="yes">CLCN7</italic>-related autosomal recessive osteopetrosis (ARO), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Full blood cell count to evaluate for leukocytosis or leukocytopenia, thrombocytopenia, and anemia with low reticulocyte count</p>
            </list-item>
            <list-item>
              <p>Investigation of calcium concentrations in blood and urine to evaluate for hypocalcemia and secondary hyperparathyroidism</p>
            </list-item>
            <list-item>
              <p>Ultrasonography of abdomen to evaluate for hepatosplenomegaly</p>
            </list-item>
            <list-item>
              <p>MRI and/or CT of the neurocranium to evaluate for narrowed neuroforamina, hydrocephalus, and brain abnormalities in neuronopathic form of osteopetrosis</p>
            </list-item>
            <list-item>
              <p>Ophthalmologic examination including VEPs to evaluate for optic nerve atrophy</p>
            </list-item>
            <list-item>
              <p>Otorhinolaryngologic examination to evaluate for choanal stenosis</p>
            </list-item>
            <list-item>
              <p>EEG to detect pathologic changes associated with neurodegeneration; neurologic examination to evaluate development</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="clcn7.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Due to the difference in severity, treatment strategies for ARO and ADOII differ. IAO lies between these two forms and has a variable prognosis. Therefore, treatment options must be evaluated on an individual basis.</p>
          <sec id="clcn7.ARO">
            <title>ARO</title>
            <p><bold>Hypocalcemic convulsions,</bold> occurring in a substantial number of neonates as the first disease manifestation, should be treated by calcium supplementation. The management of calcium homeostasis may be difficult and recommendations are conflicting: whereas physiologic doses of calcium and vitamin D have been used to treat children with osteopetrosis who have rickets, restriction of calcium and vitamin D has been used to prevent progression of disease and hypercalcemic crisis following hematopoietic stem cell transplantation (HSCT). Treatment needs to take into account the particular situation of the affected individual.</p>
            <p><bold>Bone marrow failure</bold> may require erythrocyte or platelet transfusions (irradiated products). In the case of leukocytopenia and/or hypogammaglobulinemia, which may develop in a subset of individuals, antibiotics and immunoglobulins may be given in a prophylactic or therapeutic manner.</p>
            <p>Newly diagnosed individuals should be transferred as soon as possible to a pediatric center experienced in allogeneic stem cell transplantation in this disease.</p>
            <p><bold>Sensory and neurologic manifestations</bold> require the collaboration of pediatricians, pediatric neurologists, ophthalmologists, and psychologists. Surgical decompression of the optic nerve, a difficult procedure, has been performed with some success to prevent vision loss [<xref ref-type="bibr" rid="clcn7.REF.hwang.2000.328">Hwang et al 2000</xref>].</p>
            <p><bold>Fractures</bold> require treatment and surveillance by an experienced bone surgeon or orthopedist in collaboration with the treating pediatrician.</p>
            <p><bold>Dental.</bold> Without HSCT, most children do not reach the age at which secondary dentition erupts. Children undergoing early HSCT may have normal secondary dentition despite defective primary dentition [<xref ref-type="bibr" rid="clcn7.REF.j_levik.2002.537">J&#x000e4;levik et al 2002</xref>].</p>
            <p>In some cases, defective tooth eruption, ankylosis, abscesses, and the formation of cysts and fistulas may require surgical intervention. Special attention is required to prevent mandibular osteomyelitis and extreme brittleness of the alveolar bone [<xref ref-type="bibr" rid="clcn7.REF.luzzi.2006.39">Luzzi et al 2006</xref>].</p>
          </sec>
          <sec id="clcn7.ADOII">
            <title>ADOII</title>
            <p>Orthopedic treatment is often required for fractures and arthritis. Post-surgical complications such as delayed union or non-union of fractures and infections are common (50%) because of the brittleness of the bones. Fractures near joints may require total joint arthroplasty [<xref ref-type="bibr" rid="clcn7.REF.strickland.2005.815">Strickland &#x00026; Berry 2005</xref>].</p>
          </sec>
        </sec>
        <sec id="clcn7.Prevention_of_Primary_Manifestatio">
          <title>Prevention of Primary Manifestations</title>
          <sec id="clcn7.ARO_1">
            <title>ARO</title>
            <p><bold>Hematopoietic stem cell transplantation (HSCT).</bold> Since the defective osteoclasts in osteopetrosis are of hematopoietic origin, allogeneic HSCT can be curative. Most manifestations (bone sclerosis, bone marrow failure, and extramedullary hematopoiesis) can be prevented or reversed by HSCT.</p>
            <p>Secondary neurosensory impairments caused by nerve compression may be prevented by early transplantation, but not reversed when they are already present.</p>
            <p>Primary neurologic problems and retinal degeneration developing in the neuronopathic form of ARO, however, are independent of the bone disease and therefore cannot be improved or prevented by HSCT. Persons with ARO resulting from <italic toggle="yes">CLCN7</italic> pathogenic variants who do not develop neurologic complications have been reported [<xref ref-type="bibr" rid="clcn7.REF.pangrazio.2010.e1071">Pangrazio et al 2010</xref>; A Schulz and U Kornak, unpublished results].</p>
            <p>It is highly important but difficult to exclude individuals with the neuronopathic form from this invasive treatment. On the other hand, HSCT should be performed as soon as possible in the majority of those without primary neurologic sequelae to prevent irreversible secondary complications, including visual impairment. The evaluation of affected individuals and treatment by HSCT should therefore be performed in experienced pediatric centers after multidisciplinary evaluation to assess the severity of the disease and individual prognostic factors.</p>
            <p>The outcome of HSCT in ARO has been analyzed in a retrospective survey of the European Society of Immunodeficiencies (ESID) and the European Group of Bone Marrow Transplantation (EBMT) [<xref ref-type="bibr" rid="clcn7.REF.sobacchi.2013.522">Sobacchi et al 2013</xref>]. The five-year disease-free survival was estimated at 88% for genoidentical transplants, 80% for matched unrelated transplants, and 66% for haploidentical transplants [<xref ref-type="bibr" rid="clcn7.REF.sobacchi.2013.522">Sobacchi et al 2013</xref>]. In a recently published report of 193 patients transplanted in various centers by a cyclophosphamide-based regimen, the five-year probabilities of survival were 62% after HLA-matched sib transplantation and 42% after alternative donor transplantation [<xref ref-type="bibr" rid="clcn7.REF.orchard.2015.270">Orchard et al 2015</xref>]. A further improved outcome was most recently reported from three large transplant centers using a fludarabine-based conditioning regimen [<xref ref-type="bibr" rid="clcn7.REF.natsheh.2016.535">Natsheh et al 2016</xref>; Schulz and Moshous, personal communication].</p>
            <p>Note: Because <italic toggle="yes">TCIRG1</italic> pathogenic variants are more often the cause of ARO than are <italic toggle="yes">CLCN7</italic> pathogenic variants, the majority of HSCTs have been performed in infants with <italic toggle="yes">TCIRG1</italic> rather than <italic toggle="yes">CLCN7</italic> pathogenic variants. However, there appears to be no significant difference in treatment outcome between individuals with <italic toggle="yes">TCIRG1</italic> and <italic toggle="yes">CLCN7</italic> pathogenic variants [A Schulz et al, unpublished results].</p>
            <p>The incidence of severe complications post-HSCT is high, particularly when alternative stem cell sources are used. Complications include rejection, delayed hematopoietic reconstitution, venous occlusive disease, pulmonary hypertension, and hypercalcemic crisis [<xref ref-type="bibr" rid="clcn7.REF.steward.2004.63">Steward et al 2004</xref>, <xref ref-type="bibr" rid="clcn7.REF.corbacioglu.2006.547">Corbacioglu et al 2006</xref>, <xref ref-type="bibr" rid="clcn7.REF.shroff.2012.1766">Shroff et al 2012</xref>].</p>
            <p>Cranial nerve dysfunction (visual impairment caused by optic nerve atrophy) is irreversible in most cases. In the authors' series including about 30 individuals, about two thirds of affected individuals were visually impaired after successful transplantation [A Schulz, unpublished results].</p>
            <p>Progressive neurologic sequelae, developmental delay, and repeated seizures occur in a subset of individuals after successful HSCT [<xref ref-type="bibr" rid="clcn7.REF.steward.2003.87">Steward 2003</xref>]. Severe neurologic manifestations other than visual impairment have been seen in about 10% of individuals in the authors' series [A Schulz, unpublished results].</p>
            <p><bold>Other.</bold> Conservative treatment strategies include stimulation of host osteoclasts with calcium restriction, calcitriol, steroids, parathyroid hormone, and interferon [<xref ref-type="bibr" rid="clcn7.REF.kocher.2003.222">Kocher &#x00026; Kasser 2003</xref>]. Since evidence for a favorable outcome in severe osteopetrosis is limited and because side effects are severe (particularly in infants), these drugs may be administered in special situations only.</p>
          </sec>
        </sec>
        <sec id="clcn7.Prevention_of_Secondary_Complicati">
          <title>Prevention of Secondary Complications</title>
          <p><bold>ARO.</bold> Restricted intake of calcium and vitamin D just before, during, and following HSCT to prevent hypercalcemia is recommended.</p>
          <p>Parents and patients should be informed about possible complications of the disease and recommendations for prevention should be given accordingly (e.g., severe CNS bleeding in patients with thrombocytopenia, pathologic fractures). Because of the heterogeneity of the disease, recommendations should be given on an individual basis.</p>
          <p><bold>ADOII.</bold> Good routine dental care and oral hygiene may help prevent osteomyelitis of the mandible.</p>
        </sec>
        <sec id="clcn7.Surveillance">
          <title>Surveillance</title>
          <p>
            <bold>ARO</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The possible manifestations and complications of osteopetrosis require repeat investigations; however, no general recommendations are available for the extent and frequency of investigations. A blood cell count and an ophthalmologic examination should be performed once a year at a minimum in all individuals with ARO.</p>
            </list-item>
            <list-item>
              <p>In individuals who have undergone HSCT, surveillance should be coordinated by the transplantation center; chimerism analysis should be performed repeatedly, as secondary graft failures have been reported. However, such individuals may be free of disease manifestation even in the case of stable mixed chimerism, if a substantial part of blood cells are donor derived (i.e., coexistence of hematopoietic cells of donor and recipient origin).</p>
            </list-item>
          </list>
          <p><bold>ADOII.</bold> In ADOII, skeletal manifestations do not progress and therefore no special surveillance is necessary.</p>
        </sec>
        <sec id="clcn7.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>
            <bold>ADOII</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Activities with high fracture risk should be avoided.</p>
            </list-item>
            <list-item>
              <p>Orthopedic surgery should only be performed when absolutely necessary and the surgeon should be aware of potential complications and difficulties in handling osteopetrotic bone.</p>
            </list-item>
          </list>
        </sec>
        <sec id="clcn7.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to clarify the genetic status of apparently asymptomatic older and younger sibs of an affected individual by molecular genetic testing of the <italic toggle="yes">CLCN7</italic> pathogenic variant(s) in the family in order to identify as early as possible those who would benefit from prompt initiation of treatment and preventive measures.</p>
          <p>See <xref ref-type="sec" rid="clcn7.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="clcn7.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
        <sec id="clcn7.Other">
          <title>Other</title>
          <p>Studies have been initiated to investigate the relation of genotype and clinical outcome after stem cell transplantation (for current information, see the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.esid.org/">European Society of Immunodeficiencies</ext-link> [ESID] and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ebmt.org/">European Group of Bone Marrow Transplantation</ext-link> [EBMT] websites).</p>
        </sec>
      </sec>
      <sec id="clcn7.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="clcn7.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">CLCN7</italic>-related osteopetrosis is inherited in an autosomal recessive or autosomal dominant manner.</p>
        </sec>
        <sec id="clcn7.Risk_to_Family_Members__Autosomal">
          <title>Risk to Family Members &#x02014; Autosomal Recessive Osteopetrosis</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">CLCN7</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic; however, no systematic studies have been performed to evaluate for subtle changes in bone mass.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic; however, no systematic studies have been performed to evaluate for subtle changes in bone mass.</p>
            </list-item>
            <list-item>
              <p>The limited data available suggest that in the presence of infantile malignant <italic toggle="yes">CLCN7</italic>-related recessive osteopetrosis (ARO), a similar presentation of the disease is expected in individuals of the same family; in particular, if the neuronopathic form of the disease was present in the proband, a primary CNS involvement is likely to be present in other affected sibs [Sobacchi, unpublished observation].</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>In general, individuals with ARO reproduce only if successfully treated by hematopoietic stem cell transplantation (HSCT).</p>
            </list-item>
            <list-item>
              <p>The offspring of an individual with autosomal recessive <italic toggle="yes">CLCN7</italic>-related osteopetrosis are obligate heterozygotes (carriers) for a pathogenic variant in <italic toggle="yes">CLCN7</italic>.</p>
            </list-item>
          </list>
          <p><bold>Other family members.</bold> Each sib of the proband's parents is at a 50% risk of being a carrier of a pathogenic variant in <italic toggle="yes">CLCN7</italic>.</p>
        </sec>
        <sec id="clcn7.Carrier_Heterozygote_Detection">
          <title>Carrier (Heterozygote) Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">CLCN7</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="clcn7.Risk_to_Family_Members__Autosomal_1">
          <title>Risk to Family Members &#x02014; Autosomal Dominant Osteopetrosis</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Most individuals diagnosed with autosomal dominant <italic toggle="yes">CLCN7</italic>-related osteopetrosis have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A proband with autosomal dominant <italic toggle="yes">CLCN7</italic>-related osteopetrosis may have the disorder as the result of a new <italic toggle="yes">CLCN7</italic> pathogenic variant. The proportion of cases caused by <italic toggle="yes">de novo</italic> pathogenic variants is unknown.</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include x-ray investigation of the skeleton and molecular genetic testing for the pathogenic variant identified in the proband. Evaluation of parents may determine that one is affected but has escaped previous diagnosis because of failure by health care professionals to recognize the syndrome and/or a milder phenotypic presentation. Therefore, an apparently negative family history cannot be confirmed until appropriate evaluations have been performed.</p>
            </list-item>
          </list>
          <p>Note: If the parent is the individual in whom the pathogenic variant first occurred, s/he may have somatic mosaicism for the variant and may be mildly/minimally affected.</p>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband's parents:</p>
              <list list-type="bullet">
                <list-item>
                  <p>If a parent of the proband is affected or has the <italic toggle="yes">CLCN7</italic> pathogenic variant, the risk to the sibs of inheriting the variant is 50%.</p>
                </list-item>
                <list-item>
                  <p>When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low.</p>
                </list-item>
                <list-item>
                  <p>If the pathogenic variant found in the proband cannot be detected in the DNA of one of the parents, the risk to sibs is low, but greater than that of the general population because of the possibility of germline mosaicism. Germline mosaicism has not been reported.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>The clinical severity of autosomal dominant osteopetrosis type II (ADOII) may vary within a family.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with autosomal dominant <italic toggle="yes">CLCN7</italic>-related osteopetrosis has a 50% chance of inheriting the pathogenic variant.</p>
          <p><bold>Other family members.</bold> The risk to other family members depends on the status of the proband's parents. If a parent has the <italic toggle="yes">CLCN7</italic> pathogenic variant, his or her family members may be at risk.</p>
        </sec>
        <sec id="clcn7.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="clcn7.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has the pathogenic variant or clinical evidence of the disorder, it is likely that the proband has a <italic toggle="yes">de novo</italic> pathogenic variant. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="clcn7.Prenatal_Testing_and_Preimplantati">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">CLCN7</italic> pathogenic variant(s) have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for <italic toggle="yes">CLCN7</italic>-related osteopetrosis are possible.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although decisions about prenatal testing are the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="clcn7.Resources">
        <title>Resources</title>
      </sec>
      <sec id="clcn7.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="clcn7.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>ARO, IAO, and ADOII are caused by osteoclast dysfunction. The osteoclast is a highly specialized cell with the unique ability to resorb large amounts of mineralized bone tissue. Like macrophages, osteoclasts are giant multinuclear cells formed by fusion of mononuclear hematopoietic precursors that subsequently differentiate under the influence of M-CSF and RANKL.</p>
          <p>After attaching to the bone surface, a sealing zone that isolates the resorption lacuna from the extracellular environment is formed. Large quantities of acidic vesicles then fuse with the plasma membrane juxtaposed to the bone surface to create the ruffled membrane. This structure is exclusively found in osteoclasts and secretes large amounts of acid into the resorption lacuna, which therefore is also referred to as an "extracellular lysosome" [<xref ref-type="bibr" rid="clcn7.REF.teitelbaum.2003.638">Teitelbaum &#x00026; Ross 2003</xref>]. The low pH is required to dissolve the bone mineral and for the optimal activity of acid hydrolases that degrade the bone matrix, particularly cathepsin K.</p>
          <p>Most forms of human osteopetrosis for which the genetic causes have been identified so far are the result of defects in the acid secretion mechanism. The ClC-7 chloride channel resides in lysosomal vesicles and in the ruffled membrane and acts as a 2Cl<sup>-</sup>/1H<sup>+</sup> exchanger transporting negative charges into the resorption lacuna in parallel to the protons pumped in this extracellular space by the ruffled membrane v-type H<sup>+</sup>-ATPase [<xref ref-type="bibr" rid="clcn7.REF.kornak.2001.205">Kornak et al 2001</xref>, <xref ref-type="bibr" rid="clcn7.REF.leisle.2011.2140">Leisle et al 2011</xref>].</p>
          <p><italic toggle="yes">TCIRG1</italic> encodes an important subunit of this H<sup>+</sup>-ATPase and carbonic anhydrase 2, encoded by <italic toggle="yes">CA2</italic>, generates the necessary protons in the osteoclast cytoplasm; thus, defects in these genes also cause osteopetrosis.</p>
          <p>Pathogenic variants in <italic toggle="yes">CLCN7</italic> lead to a loss of chloride channel function of varying degree. In the most severe cases of ARO, H(+)/Cl(-) exchange transporter 7 (also known as ClC-7) is absent. As illustrated by a knockout mouse model, which shows degeneration of the CNS and the retina, a complete loss of the protein entails a strong risk for the neuronopathic form of ARO [<xref ref-type="bibr" rid="clcn7.REF.kornak.2001.205">Kornak et al 2001</xref>, <xref ref-type="bibr" rid="clcn7.REF.steward.2003.87">Steward 2003</xref>, <xref ref-type="bibr" rid="clcn7.REF.kasper.2005.1079">Kasper et al 2005</xref>].</p>
          <p>The less severe forms of osteopetrosis are thought to be caused by pathogenic variants that incompletely inactivate the protein. Pathogenic variants found in <italic toggle="yes">ADOII</italic> apparently have dominant-negative effects. It has been shown that these pathogenic variants affect chloride channel function, as has been described for the Thomsen type of <related-object link-type="booklink" source-id="gene" document-id="myotonia-c" document-type="chapter">myotonia congenita</related-object>, caused by dominant pathogenic variants in <italic toggle="yes">CLCN1</italic> [<xref ref-type="bibr" rid="clcn7.REF.jentsch.2005b.779">Jentsch et al 2005b</xref>]. Some <italic toggle="yes">CLCN7</italic> pathogenic variants have been reported to alter expression and subcellular localization of the protein. Electrophysiologic measurement of a ClC-7 variant localizing to the plasma membrane demonstrated that ADOII-causing pathogenic variants do not necessarily impair chloride currents, but do result in abnormal gating behavior of the channel [<xref ref-type="bibr" rid="clcn7.REF.leisle.2011.2140">Leisle et al 2011</xref>].</p>
          <p><bold>Gene structure.</bold> The most relevant <italic toggle="yes">CLCN7</italic> transcript (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_001287.5">NM_001287.5</ext-link>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/CCDS/CcdsBrowse.cgi?REQUEST=GENEID&#x00026;DATA=1186">CCDS 32361.1</ext-link>) contains a coding region of 2418 bp subdivided into 25 exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="clcn7" object-id="clcn7.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Pathogenic variants.</bold> Pathogenic variants found in ARO comprise nonsense variants (7.4%), frameshifts caused by splicing defects and indels (25.5%), in-frame deletions (0.01%) and missense variants (66%). Approximately 28.7% of these pathogenic variants reside in the C-terminal CBS domains of the protein. A homozygous contiguous gene deletion has also been identified in one individual with ARO [<xref ref-type="bibr" rid="clcn7.REF.pangrazio.2012.250">Pangrazio et al 2012</xref>]. In <italic toggle="yes">ADOII</italic>, pathogenic variants comprise nonsense variants (2.5%), frameshifts (12.5%), inframe deletions (2.5%) and missense variants (82.5%). Approximately 45% of these pathogenic variants are found in the C-terminal CBS domains [Sobacchi, unpublished].</p>
          <table-wrap id="clcn7.T.clcn7_variants_discussed_in_this" orientation="portrait" position="anchor">
            <label>Table 4. </label>
            <caption>
              <p><italic toggle="yes">CLCN7</italic> Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_clcn7.T.clcn7_variants_discussed_in_this_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant Classification</th>
                  <th id="hd_h_clcn7.T.clcn7_variants_discussed_in_this_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                  <th id="hd_h_clcn7.T.clcn7_variants_discussed_in_this_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                  <th id="hd_h_clcn7.T.clcn7_variants_discussed_in_this_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_clcn7.T.clcn7_variants_discussed_in_this_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>Benign</bold>
                  </td>
                  <td headers="hd_h_clcn7.T.clcn7_variants_discussed_in_this_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.1252G&#x0003e;A</td>
                  <td headers="hd_h_clcn7.T.clcn7_variants_discussed_in_this_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Val418Met</td>
                  <td headers="hd_h_clcn7.T.clcn7_variants_discussed_in_this_1_1_1_4" rowspan="4" valign="middle" align="left" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_001287.5">NM_001287.5</ext-link>
                    <break/>
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_001278.1">NP_001278.1</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_clcn7.T.clcn7_variants_discussed_in_this_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                    <bold>Pathogenic</bold>
                  </td>
                  <td headers="hd_h_clcn7.T.clcn7_variants_discussed_in_this_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.296A&#x0003e;G</td>
                  <td headers="hd_h_clcn7.T.clcn7_variants_discussed_in_this_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Tyr99Cys</td>
                </tr>
                <tr>
                  <td headers="hd_h_clcn7.T.clcn7_variants_discussed_in_this_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.643G&#x0003e;A</td>
                  <td headers="hd_h_clcn7.T.clcn7_variants_discussed_in_this_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly215Arg</td>
                </tr>
                <tr>
                  <td headers="hd_h_clcn7.T.clcn7_variants_discussed_in_this_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">c.2299C&#x0003e;T</td>
                  <td headers="hd_h_clcn7.T.clcn7_variants_discussed_in_this_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg767Trp</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold>
<italic toggle="yes">CLCN7</italic> encodes the 805-amino acid H(+)/Cl(-) exchange transporter 7 (ClC-7), which resides in late endosomes and lysosomes of most cell types. In osteoclasts, the protein is translocated to the ruffled membrane. Like the other CLC channels, ClC-7 contains two C-terminal CBS domains, assumed to be involved in protein-protein interaction. This interaction may facilitate the formation of the functional channel dimers. CLC channels are not pure chloride channels but rather function as chloride/proton antiporters [<xref ref-type="bibr" rid="clcn7.REF.jentsch.2005a.2039">Jentsch et al 2005a</xref>]. The OSTM1 protein is a subunit of the functional CLC channels and influences their behavior [<xref ref-type="bibr" rid="clcn7.REF.lange.2006.220">Lange et al 2006</xref>, <xref ref-type="bibr" rid="clcn7.REF.leisle.2011.2140">Leisle et al 2011</xref>]. When driven to the plasma membrane the protein complex shows slow gating and outwardly rectifying chloride currents [<xref ref-type="bibr" rid="clcn7.REF.leisle.2011.2140">Leisle et al 2011</xref>].</p>
          <p><bold>Abnormal gene product.</bold> A complete loss of the ClC-7 protein abolished osteoclast resorptive activity in mice with <italic toggle="yes">Clcn7</italic><sup>&#x02212;/&#x02212;</sup> osteoclasts; similarly, some individuals with malignant infantile osteopetrosis had one null allele [<xref ref-type="bibr" rid="clcn7.REF.kornak.2001.205">Kornak et al 2001</xref>]. The situation for missense variants is less clear. Only a minority of ClC-7 mutants have been tested for their stability and subcellular distribution. The tested pathogenic missense variants show variable effects [<xref ref-type="bibr" rid="clcn7.REF.schulz.2010.e12585">Schulz et al 2010</xref>, <xref ref-type="bibr" rid="clcn7.REF.leisle.2011.2140">Leisle et al 2011</xref>]. Among the pathogenic variants associated with ADOII tested in vitro (10 of 40 total variants), the majority alter the electrophysiologic properties of the channel [<xref ref-type="bibr" rid="clcn7.REF.leisle.2011.2140">Leisle et al 2011</xref>]. Interestingly, some of these variants showed normal current amplitudes and even accelerated gating. These alterations are thought to lead to the variable attenuation of osteoclast activity &#x02013; giving rise to the variability of the clinical course [<xref ref-type="bibr" rid="clcn7.REF.chu.2006.1089">Chu et al 2006</xref>, <xref ref-type="bibr" rid="clcn7.REF.del_fattore.2006.315">Del Fattore et al 2006</xref>].</p>
        </sec>
      </sec>
      <sec id="clcn7.References">
        <title>References</title>
        <sec id="clcn7.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="clcn7.Literature_Cited.reflist0">
            <ref id="clcn7.REF.aker.2012.221">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aker</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouvinski</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hashavia</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ta-Shma</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaag</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zenvirt</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Israel</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weintraub</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taraboulos</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bar-Shavit</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elpeleg</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>An SNX10 mutation causes malignant osteopetrosis of infancy.</article-title>
                <source>J Med Genet</source>
                <volume>49</volume>
                <fpage>221</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">22499339</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.b_nichou.2001.647">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>B&#x000e9;nichou</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cleiren</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gram</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bollerslev</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vernejoul</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hul</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Mapping of autosomal dominant osteopetrosis type II (Albers-Sch&#x000f6;nberg disease) to chromosome 16p13.3.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2001</year>
                <volume>69</volume>
                <fpage>647</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">11468688</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.b_nichou.2000.87">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>B&#x000e9;nichou</surname>
                    <given-names>OD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laredo</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vernejoul</surname>
                    <given-names>MC</given-names>
                  </name>
                </person-group>
                <article-title>Type II autosomal dominant osteopetrosis (Albers-Sch&#x000f6;nberg disease): clinical and radiological manifestations in 42 patients.</article-title>
                <source>Bone.</source>
                <year>2000</year>
                <volume>26</volume>
                <fpage>87</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">10617161</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.bliznetz.2009.664">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bliznetz</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tverskaya</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zinchenko</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abrukova</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savaskina</surname>
                    <given-names>EN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nikulin</surname>
                    <given-names>MV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirillov</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ginter</surname>
                    <given-names>EK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polyakov</surname>
                    <given-names>AV</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Genetic analysis of autosomal recessive osteopetrosis in Chuvashiya: the unique splice site mutation in TCIRG1 gene spread by the founder effect.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>17</volume>
                <fpage>664</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">19172990</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.bollerslev.1989.45">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bollerslev</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1989</year>
                <article-title>Autosomal dominant osteopetrosis: bone metabolism and epidemiological, clinical, and hormonal aspects.</article-title>
                <source>Endocr Rev</source>
                <volume>10</volume>
                <fpage>45</fpage>
                <lpage>67</lpage>
                <pub-id pub-id-type="pmid">2666111</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.bolt.2005.e71">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bolt</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wennink</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verbeke</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shah</surname>
                    <given-names>GN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sly</surname>
                    <given-names>WS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000f6;kenkamp</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <article-title>Carbonic anhydrase type II deficiency.</article-title>
                <source>Am J Kidney Dis.</source>
                <year>2005</year>
                <volume>46</volume>
                <issue>A50</issue>
                <fpage>e71</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">16265785</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.braun.2001.74">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Braun</surname>
                    <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nurnberg</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tinschert</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Metaphyseal dysplasia: a new autosomal dominant type in a large German kindred.</article-title>
                <source>Am J Med Genet</source>
                <volume>101</volume>
                <fpage>74</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11343343</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.campeau.2012.4904">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Campeau</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sule</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bae</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Madan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000f6;gler</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mumm</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibbs</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whyte</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>BH</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Whole-exome sequencing identifies mutations in the nucleoside transporter gene SLC29A3 in dysosteosclerosis, a form of osteopetrosis.</article-title>
                <source>Hum Mol Genet</source>
                <volume>21</volume>
                <fpage>4904</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">22875837</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.camposxavier.2003.186">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Campos-Xavier</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saraiva</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ribeiro</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cormier-Daire</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Chloride channel 7 (CLCN7) gene mutations in intermediate autosomal recessive osteopetrosis.</article-title>
                <source>Hum Genet</source>
                <volume>112</volume>
                <fpage>186</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12522560</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.chu.2006.1089">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chu</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snyder</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Econs</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties.</article-title>
                <source>J Bone Miner Res</source>
                <volume>21</volume>
                <fpage>1089</fpage>
                <lpage>97</lpage>
                <pub-id pub-id-type="pmid">16813529</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.cleiren.2001.2861">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cleiren</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000e9;nichou</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hul</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gram</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bollerslev</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singer</surname>
                    <given-names>FR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beaverson</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aledo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whyte</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoneyama</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>deVernejoul</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hul</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Albers-Schonberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene.</article-title>
                <source>Hum Mol Genet</source>
                <volume>10</volume>
                <fpage>2861</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11741829</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.corbacioglu.2006.547">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Corbacioglu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000f6;nig</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lahr</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>St&#x000f6;hr</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berry</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedrich</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulz</surname>
                    <given-names>AS</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Stem cell transplantation in children with infantile osteopetrosis is associated with a high incidence of VOD, which could be prevented with defibrotide.</article-title>
                <source>Bone Marrow Transplant</source>
                <volume>38</volume>
                <fpage>547</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">16953210</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.crazzolara.2015.1677">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Crazzolara</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maurer</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulze</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zieger</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zustin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulz</surname>
                    <given-names>AS</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>A new mutation in the KINDLIN-3 gene ablates integrin-dependent leukocyte, platelet, and osteoclast function in a patient with leukocyte adhesion deficiency-III</article-title>
                <source>Pediatr Blood Cancer</source>
                <volume>62</volume>
                <fpage>1677</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">25854317</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.del_fattore.2006.315">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Del Fattore</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peruzzi</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rucci</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Recchia</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cappariello</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Longo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fortunati</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballanti</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iacobini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luciani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devito</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinto</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caniglia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lanino</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Messina</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cesaro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Letizia</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bianchini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fryssira</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grabowski</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bishop</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kapur</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Datta</surname>
                    <given-names>HK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taranta</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fornari</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Migliaccio</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teti</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment.</article-title>
                <source>J Med Genet</source>
                <volume>43</volume>
                <fpage>315</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">16118345</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.dozier.2005.762">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dozier</surname>
                    <given-names>TS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duncan</surname>
                    <given-names>IM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lambert</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Key</surname>
                    <given-names>LL</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Otologic manifestations of malignant osteopetrosis.</article-title>
                <source>Otol Neurotol</source>
                <volume>26</volume>
                <fpage>762</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16015181</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.frattini.2000.343">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Frattini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orchard</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobacchi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giliani</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abinun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mattsson</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keeling</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andersson</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallbrandt</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zecca</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Notarangelo</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vezzoni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villa</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis.</article-title>
                <source>Nat Genet</source>
                <volume>25</volume>
                <fpage>343</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">10888887</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.frattini.2003.1740">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Frattini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pangrazio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Susani</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobacchi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mirolo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abinun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andolina</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horwitz</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mihci</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Notarangelo</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramenghi</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hove</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vujic</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albertini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orchard</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vezzoni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villa</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis.</article-title>
                <source>J Bone Miner Res</source>
                <volume>18</volume>
                <fpage>1740</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">14584882</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.gelb.1996.1236">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gelb</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shi</surname>
                    <given-names>GP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chapman</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desnick</surname>
                    <given-names>RJ</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency.</article-title>
                <source>Science</source>
                <volume>273</volume>
                <fpage>1236</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">8703060</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.guerrini.2008.64">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guerrini</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobacchi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cassani</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abinun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kilic</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pangrazio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moratto</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazzolari</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clayton-Smith</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orchard</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coxon</surname>
                    <given-names>FP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Helfrich</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crockett</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mellis</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vellodi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tezcan</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Notarangelo</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogers</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vezzoni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frattini</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Humanosteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations.</article-title>
                <source>Am J Hum Genet</source>
                <volume>83</volume>
                <fpage>64</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">18606301</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.hamersma.2003.192">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hamersma</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gardner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beighton</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>The natural history of sclerosteosis.</article-title>
                <source>Clin Genet</source>
                <volume>63</volume>
                <fpage>192</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12694228</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.helfrich.2005.115">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Helfrich</surname>
                    <given-names>MH</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Osteoclast diseases and dental abnormalities.</article-title>
                <source>Arch Oral Biol</source>
                <volume>50</volume>
                <fpage>115</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">15721137</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.hu.2013.e73576">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>IP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Almeida</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tiziani</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Do Amaral</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gowrishankar</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Passos-Bueno</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reichenberger</surname>
                    <given-names>EJ</given-names>
                  </name>
                </person-group>
                <article-title>A novel autosomal recessive GJA1 missense mutation linked to Craniometaphyseal dysplasia.</article-title>
                <source>PLoS One.</source>
                <year>2013</year>
                <volume>8</volume>
                <fpage>e73576</fpage>
                <pub-id pub-id-type="pmid">23951358</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.hwang.2000.328">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hwang</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>IO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>KC</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Complete visual recovery in osteopetrosis by early optic nerve decompression.</article-title>
                <source>Pediatr Neurosurg</source>
                <volume>33</volume>
                <fpage>328</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">11182645</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.iughetti.2000.482">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Iughetti</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alonso</surname>
                    <given-names>LG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilcox</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alonso</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Passos-Bueno</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Mapping of the autosomal recessive (AR) craniometaphyseal dysplasia locus to chromosome region 6q21-22 and confirmation of genetic heterogeneity for mild AR spondylocostal dysplasia.</article-title>
                <source>Am J Med Genet</source>
                <volume>95</volume>
                <fpage>482</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">11146471</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.jacquemin.1998.662">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jacquemin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mullaney</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Svedberg</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Marble brain syndrome: osteopetrosis, renal acidosis and calcification of the brain.</article-title>
                <source>Neuroradiology</source>
                <volume>40</volume>
                <fpage>662</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">9833897</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.j_levik.2002.537">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>J&#x000e4;levik</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fasth</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahll&#x000f6;f</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Dental development after successful treatment of infantile osteopetrosis with bone marrow transplantation.</article-title>
                <source>Bone Marrow Transplant.</source>
                <year>2002</year>
                <volume>29</volume>
                <fpage>537</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">11960278</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.jentsch.2005a.2039">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jentsch</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maritzen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zdebik</surname>
                    <given-names>AA</given-names>
                  </name>
                </person-group>
                <year>2005a</year>
                <article-title>Chloride channel diseases resulting from impaired transepithelial transport or vesicular function.</article-title>
                <source>J Clin Invest</source>
                <volume>115</volume>
                <fpage>2039</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">16075045</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.jentsch.2005b.779">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jentsch</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poet</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fuhrmann</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zdebik</surname>
                    <given-names>AA</given-names>
                  </name>
                </person-group>
                <year>2005b</year>
                <article-title>Physiological functions of CLC</article-title>
                <source>Annu Rev Physiol</source>
                <volume>67</volume>
                <fpage>779</fpage>
                <lpage>807</lpage>
                <pub-id pub-id-type="pmid">15709978</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.kasper.2005.1079">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kasper</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Planells-Cases</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fuhrmann</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheel</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeitz</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruether</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmitt</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poet</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinfeld</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schweizer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kornak</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jentsch</surname>
                    <given-names>TJ</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration.</article-title>
                <source>EMBO J</source>
                <volume>24</volume>
                <fpage>1079</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">15706348</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.kocher.2003.222">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kocher</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kasser</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Osteopetrosis.</article-title>
                <source>Am J Orthop</source>
                <volume>32</volume>
                <fpage>222</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12772872</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.kornak.2001.205">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kornak</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kasper</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bosl</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaiser</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schweizer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedrich</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delling</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jentsch</surname>
                    <given-names>TJ</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man.</article-title>
                <source>Cell</source>
                <volume>104</volume>
                <fpage>205</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">11207362</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.kornak.2000.2059">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kornak</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedrich</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uhlhaas</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kremens</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voit</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasan</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bode</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jentsch</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kubisch</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis.</article-title>
                <source>Hum Mol Genet</source>
                <volume>9</volume>
                <fpage>2059</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">10942435</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.lange.2006.220">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lange</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wartosch</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jentsch</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fuhrmann</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function.</article-title>
                <source>Nature</source>
                <volume>440</volume>
                <fpage>220</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">16525474</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.leisle.2011.2140">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leisle</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ludwig</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jentsch</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stauber</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>ClC-7 is a slowly voltage-gated 2Cl(-)/1H(+)-exchanger and requires Ostm1 for transport activity.</article-title>
                <source>EMBO J.</source>
                <year>2011</year>
                <volume>30</volume>
                <fpage>2140</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">21527911</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.luzzi.2006.39">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Luzzi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Consoli</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daryanani</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santoro</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sfasciotti</surname>
                    <given-names>GL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polimeni</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Malignant infantile osteopetrosis: dental effects in paediatric patients. Case reports.</article-title>
                <source>Eur J Paediatr Dent</source>
                <volume>7</volume>
                <fpage>39</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">16646644</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.natsheh.2016.535">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Natsheh</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drozdinsky</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simanovsky</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamdan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erlich</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorelik</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Or</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weintraub</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stepensky</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2016</year>
                <article-title>Improved outcomes of hematopoietic stem cell transplantation in patients with infantile malignant osteopetrosis using fludarabine-based conditioning.</article-title>
                <source>Pediatr Blood Cancer.</source>
                <volume>63</volume>
                <fpage>535</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">26485304</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.n_rnberg.2001.37">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>N&#x000fc;rnberg</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thiele</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chandler</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>H&#x000f6;hne</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cunningham</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ritter</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leschik</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uhlmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mischung</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harrop</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldblatt</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borochowitz</surname>
                    <given-names>ZU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kotzot</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Westermann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mundlos</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Braun</surname>
                    <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laing</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tinschert</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia.</article-title>
                <source>Nat Genet.</source>
                <year>2001</year>
                <volume>28</volume>
                <fpage>37</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">11326272</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.ott.2013.292">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ott</surname>
                    <given-names>C-E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schr&#x000f6;ter</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richter</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gupta</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verma</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kabra</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mundlos</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajab</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neitzel</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kornak</surname>
                    <given-names>U</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Severe neuronopathic autosomal recessive osteopetrosis due to homozygous deletions affecting OSTM1.</article-title>
                <source>Bone</source>
                <volume>55</volume>
                <fpage>292</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">23685543</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.orchard.2015.270">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Orchard</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fasth</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Rademacher</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boelens</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horwitz</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Seraihy</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ayas</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonfim</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boulad</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lund</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buchbinder</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kapoor</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Brien</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perez</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veys</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eapen</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Hematopoietic stem cell transplantation for infantile osteopetrosis.</article-title>
                <source>Blood</source>
                <volume>126</volume>
                <fpage>270</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">26012570</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.palagano.2015.1814">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Palagano</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blair</surname>
                    <given-names>HC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pangrazio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tourkova</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strina</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angius</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cuccuru</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oppo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uva</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hul</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boudin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faletra</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nocerino</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grappiolo</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monari</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montanelli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vezzoni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobacchi</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Buried in the Middle but Guilty: Intronic Mutations in the TCIRG1 Gene Cause Human Autosomal Recessive Osteopetrosis.</article-title>
                <source>J Bone Miner Res</source>
                <volume>30</volume>
                <fpage>1814</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">25829125</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.pangrazio.2013.1041">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pangrazio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fasth</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sbardellati</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orchard</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kasow</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raza</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albayrak</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albayrak</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanakker</surname>
                    <given-names>OM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Moerloose</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vellodi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Notarangelo</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlack</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strauss</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x000fc;hl</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caldana</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iacono</surname>
                    <given-names>NL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Susani</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kornak</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vezzoni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobacchi</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>SNX10 mutations define a subgroup of human autosomal recessive osteopetrosis with variable clinical severity.</article-title>
                <source>J Bone Miner Res</source>
                <volume>28</volume>
                <fpage>1041</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">23280965</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.pangrazio.2012.250">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pangrazio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frattini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valli</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maserati</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Susani</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vezzoni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Herz</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobacchi</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>A homozygous contiguous gene deletion in chromosome 16p13.3 leads to autosomal recessive osteopetrosis in a Jordanian patient.</article-title>
                <source>Calcif Tissue Int</source>
                <volume>91</volume>
                <fpage>250</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">22847576</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.pangrazio.2006.1098">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pangrazio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poliani</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Megarbane</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lefranc</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lanino</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Rocco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rucci</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucchini</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ravanini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Facchetti</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abinun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vezzoni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frattini</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Mutations in OSTM1 (grey lethal) define a particularly severe form of autosomal recessive osteopetrosis with neural involvement.</article-title>
                <source>J Bone Miner Res</source>
                <volume>21</volume>
                <fpage>1098</fpage>
                <lpage>105</lpage>
                <pub-id pub-id-type="pmid">16813530</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.pangrazio.2010.e1071">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pangrazio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pusch</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caldana</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frattini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lanino</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamhankar</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phadke</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orchard</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mihci</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abinun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wright</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vettenranta</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bariae</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Melis</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tezcan</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumann</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Locatelli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zecca</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horwitz</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mansour</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Roij</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vezzoni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobacchi</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Molecular and clinical heterogeneity in CLCN7-dependent osteopetrosis: report of 20 novel mutations.</article-title>
                <source>Hum Mutat.</source>
                <volume>31</volume>
                <fpage>E1071</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">19953639</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.pangrazio.2014.122">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pangrazio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puddu</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oppo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valentini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zammataro</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vellodi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gener</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Llano-Rivas</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raza</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atta</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vezzoni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti-Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobacchi</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Exome sequencing identifies CTSK mutations in patients originally diagnosed as intermediate osteopetrosis.</article-title>
                <source>Bone</source>
                <volume>59</volume>
                <fpage>122</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">24269275</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.schulz.2010.e12585">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schulz</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Werner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stauber</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henriksen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fendler</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>The G215R mutation in the Cl-/H+-antiporter ClC-7 found in ADO II osteopetrosis does not abolish function but causes a severe trafficking defect.</article-title>
                <source>PLoS One</source>
                <volume>5</volume>
                <fpage>e12585</fpage>
                <pub-id pub-id-type="pmid">20830208</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.shroff.2012.1766">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shroff</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beringer</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rao</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofbauer</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulz</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Denosumab for post-transplantation hypercalcemia in osteopetrosis</article-title>
                <source>N Engl J Med</source>
                <volume>367</volume>
                <fpage>1766</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">23113501</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.sobacchi.2001.1767">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sobacchi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frattini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orchard</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porras</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tezcan</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andolina</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Babul-Hirji</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baric</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Canham</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chitayat</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dupuis-Girod</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellis</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Etzioni</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fasth</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fisher</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerritsen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gulino</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horwitz</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klamroth</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lanino</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mirolo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Musio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matthijs</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nonomaya</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Notarangelo</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ochs</surname>
                    <given-names>HD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Superti Furga</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valiaho</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Hove</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vihinen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vujic</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vezzoni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villa</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>The mutational spectrum of human malignant autosomal recessive osteopetrosis.</article-title>
                <source>Hum Mol Genet</source>
                <volume>10</volume>
                <fpage>1767</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">11532986</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.sobacchi.2007.960">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sobacchi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frattini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrini</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abinun</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pangrazio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Susani</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bredius</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cant</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bishop</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grabowski</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Fattore</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Messina</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Errigo</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coxon</surname>
                    <given-names>FP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scott</surname>
                    <given-names>DI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogers</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vezzoni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villa A Helfrich</surname>
                    <given-names>MH</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL.</article-title>
                <source>Nat Genet</source>
                <volume>39</volume>
                <fpage>960</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">17632511</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.sobacchi.2014.1646">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sobacchi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pangrazio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gomez</surname>
                    <given-names>DP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caldana</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Susani</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vezzoni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villa</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>As little as needed: the extraordinary case of a mild recessive osteopetrosis owing to a novel splicing hypomorphic mutation in the TCIRG1 gene.</article-title>
                <source>J Bone Miner Res</source>
                <volume>29</volume>
                <fpage>1646</fpage>
                <lpage>50</lpage>
                <pub-id pub-id-type="pmid">24535816</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.souraty.2007.188">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Souraty</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noun</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Djambas-Khayat</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chouery</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pangrazio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lefranc</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frattini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000e9;garban&#x000e9;</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Molecular study of six families originating from the Middle-East and presenting with autosomal recessive osteopetrosis.</article-title>
                <source>Eur J Med Genet</source>
                <volume>50</volume>
                <fpage>188</fpage>
                <lpage>99</lpage>
                <pub-id pub-id-type="pmid">17400532</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.steward.2003.87">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Steward</surname>
                    <given-names>CG</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Neurological aspects of osteopetrosis.</article-title>
                <source>Neuropathol Appl Neurobiol</source>
                <volume>29</volume>
                <fpage>87</fpage>
                <lpage>97</lpage>
                <pub-id pub-id-type="pmid">12662317</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.steward.2004.63">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Steward</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pellier</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahajan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashworth</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stuart</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fasth</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedrich</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulz</surname>
                    <given-names>AS</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Severe pulmonary hypertension: a frequent complication of stem cell transplantation for malignant infantile osteopetrosis.</article-title>
                <source>Br J Haematol</source>
                <volume>124</volume>
                <fpage>63</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">14675409</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.strickland.2005.815">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Strickland</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berry</surname>
                    <given-names>DJ</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Total joint arthroplasty in patients with osteopetrosis: a report of 5 cases and review of the literature.</article-title>
                <source>J Arthroplasty</source>
                <volume>20</volume>
                <fpage>815</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">16139724</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.teitelbaum.2003.638">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Teitelbaum</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>FP</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Genetic regulation of osteoclast development and function.</article-title>
                <source>Nat Rev Genet</source>
                <volume>4</volume>
                <fpage>638</fpage>
                <lpage>49</lpage>
                <pub-id pub-id-type="pmid">12897775</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.van_wesenbeeck.2003.763">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Van Wesenbeeck</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cleiren</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gram</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beals</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000e9;nichou</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scopelliti</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Key</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Renton</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartels</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gong</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warman</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vernejoul</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bollerslev</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hul</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density.</article-title>
                <source>Am J Hum Genet</source>
                <volume>72</volume>
                <fpage>763</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">12579474</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.van_wesenbeeck.2007.919">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Van Wesenbeeck</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Odgren</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coxon</surname>
                    <given-names>FP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frattini</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moens</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perdu</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacKay</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hul</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmermans</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanhoenacker</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacobs</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peruzzi</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Helfrich</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogers</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hul</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Involvement of PLEKHM1 in osteoclastic vesicular transport and osteopetrosis in incisors absent rats and humans.</article-title>
                <source>J Clin Invest</source>
                <volume>117</volume>
                <fpage>919</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">17404618</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.vanhoenacker.2000.1423">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vanhoenacker</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Beuckeleer</surname>
                    <given-names>LH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hul</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balemans</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Schepper</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Sclerosing bone dysplasias: genetic and radioclinical features.</article-title>
                <source>Eur Radiol</source>
                <volume>10</volume>
                <fpage>1423</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">10997431</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.waguespack.2003.1513">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Waguespack</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koller</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fishburn</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carn</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buckwalter</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kocisko</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evans</surname>
                    <given-names>WE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foroud</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Econs</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Chloride channel 7 (ClCN7) gene mutations and autosomal dominant osteopetrosis, type II.</article-title>
                <source>J Bone Miner Res</source>
                <volume>18</volume>
                <fpage>1513</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12929941</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.wilson.2000.449">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vellodi</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Autosomal recessive osteopetrosis: diagnosis, management, and outcome.</article-title>
                <source>Arch Dis Child</source>
                <volume>83</volume>
                <fpage>449</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">11040159</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="clcn7.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="clcn7.Suggested_Reading.reflist0">
            <ref id="clcn7.REF.de_vernejoul.2010.269">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Vernejoul</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kornak</surname>
                    <given-names>U</given-names>
                  </name>
                </person-group>
                <article-title>Heritable sclerosing bone disorders: presentation and new molecular mechanisms</article-title>
                <year>2010</year>
                <source>Ann N Y Acad Sci</source>
                <volume>1192</volume>
                <fpage>269</fpage>
                <lpage>77</lpage>
                <pub-id pub-id-type="pmid">20392246</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.sobacchi.2013.522">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sobacchi</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schulz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coxon</surname>
                    <given-names>FP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Helfrich</surname>
                    <given-names>MH</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Osteopetrosis: genetics, treatment and new insights into osteoclast function.</article-title>
                <source>Nat Rev Endocrinol</source>
                <volume>9</volume>
                <fpage>522</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">23877423</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.tolar.2004.2839">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tolar</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teitelbaum</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orchard</surname>
                    <given-names>PJ</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Osteopetrosis.</article-title>
                <source>N Engl J Med</source>
                <volume>351</volume>
                <fpage>2839</fpage>
                <lpage>49</lpage>
                <pub-id pub-id-type="pmid">15625335</pub-id>
              </element-citation>
            </ref>
            <ref id="clcn7.REF.villa.2009.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Villa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrini</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cassani</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pangrazio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sobacchi</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Infantile malignant, autosomal recessive osteopetrosis: the rich and the poor.</article-title>
                <source>Calcif Tissue Int.</source>
                <volume>84</volume>
                <fpage>1</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">19082854</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="clcn7.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="clcn7.Author_Information">
          <title>Author Information</title>
          <p>Guidelines for diagnosis, therapy, and follow up for this disorder are available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ebmt.org/Contents/About-EBMT/Who-We-Are/ScientificCouncil/Documents/00_OP_Guidelines_02122011.pdf">online</ext-link> (pdf) and from author Ansgar Schulz, MD at ansgar.schulz@uniklinik-ulm.de.</p>
        </sec>
        <sec id="clcn7.Author_History">
          <title>Author History</title>
          <p>Marie-Christine de Vernejoul, MD, PhD; H&#x000f4;pital Lariboisi&#x000e8;re (2007-2016)Uwe Kornak, MD, PhD (2007-present)Ansgar Schulz, MD (2007-present)Cristina Sobacchi, MS (2016-present)Anna Villa, MD, PhD (2016-present)</p>
        </sec>
        <sec id="clcn7.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>9 June 2016 (ha) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>20 June 2013 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>14 October 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>12 February 2007 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>8 September 2006 (uk) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="clcn7.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>ARO x-rays</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="clcn7-Image001" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="clcn7.F2" orientation="portrait">
          <label>Figure 2. </label>
          <caption>
            <p>ADOII x-rays Reprinted from <xref ref-type="bibr" rid="clcn7.REF.b_nichou.2000.87">B&#x000e9;nichou et al [2000]</xref> with permission from Elsevier</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="clcn7-Image002" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
